Skip to main content
. 2023 Jan 25;24:30. doi: 10.1186/s12931-023-02316-6

Fig. 3.

Fig. 3

Clinical measures of disease severity and symptoms including (A) FEV1 percent predicted, (B) FEV1/FVC, (C) DLCO percent predicted (D) distance walked in six minutes, (E) SGRQ total score, (F) MMRC dyspnea score, and (G) BODE index, varying by cluster in the COPDGene discovery sample set as well as in the COPDGene and MESA validation sets. Some measures were not present in the MESA cohort. BODE body mass index, airflow obstruction, dyspnea, and exercise capacity, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, MMRC Modified Medical Research Council Dyspnea Scale, SGRQ St. George’s Respiratory Questionnaire